News
2d
Medical Device Network on MSNGHIT Fund grants $4.5m to Fluxus for tuberculosis urine test developmentFund has awarded a $4.5m grant to US-based diagnostic developer Fluxus, a Fujirebio subsidiary, to develop an ultrasensitive ...
Saliva is easier to obtain than blood or sputum, and the ability to non-invasively obtain samples that yield accurate results is critical for successfully testing children. More than 1 million ...
TB remains a critical public health concern in low-income countries and diagnosis using a cheap, simple test like we've developed is needed not only to treat patients with TB but prevent further ...
“The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test gives laboratories the ability to process latent TB tests at higher volumes without compromising clinical accuracy,” said Yves ...
Can you elaborate on your advocacy with diagnostic company Danaher to reduce TB test prices? Danaher manufactures a molecular test called GeneXpert, which can tell whether someone has TB within tw ...
The US Food and Drug Administration (FDA) has granted approval for Revvity’s Auto-Pure 2400 liquid handling platform, used in conjunction with the T-SPOT.TB test. This approval introduces an ...
"Individuals with latent TB infection have had a positive test result, but they do not feel sick, do not have symptoms and cannot spread TB germs to others," according to Lake County health officials.
VIZIANAGARAM: Vizianagaram district has emerged as the top performer among 347 districts across India in tuberculosis (TB) testing under the 100-Day TB-Mukt Bharat Abhiyaan, launched on December 7 ...
The termination of United States funding for HIV and tuberculosis research programmes in South Africa could undo years of progress and fuel a global health crisis, because TB remains a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results